Report Detail

Request for Sample of this report

Other Global Pulmonary Drug Delivery Systems Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2952594
    • |
  • 15 February, 2019
    • |
  • Global
    • |
  • 135 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.

Scope of the Report:
With better performance, the development of DPIs is faster than the MDIs. In the future, DPIs will occupy larger market share and replace the MDIs gradually. In addition, the market share of nebulizers will be smaller.
As WHO said, the COPD will become the world's third-leading cause of death by 2030. With the air pollution more and more serious, patients with respiratory diseases will be more and more, which means larger and larger demand for pulmonary drug delivery systems.
The worldwide market for Pulmonary Drug Delivery Systems is expected to grow at a CAGR of roughly 5.3% over the next five years, will reach 3490 million US$ in 2024, from 2560 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Pulmonary Drug Delivery Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
3M
GSK
AstraZeneca
Cipla
Chiesi
Boehringer Ingelheim
Aptar
Novartis
Philips Respironics
Omron Healthcare
PARI
Skyepharma
CareFusion
Shanghai Huarui
Taian Character
Chia Tai Tianqing

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Nebulizers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)

Market Segment by Applications, can be divided into
COPD
Asthma
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pulmonary Drug Delivery Systems product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pulmonary Drug Delivery Systems, with price, sales, revenue and global market share of Pulmonary Drug Delivery Systems in 2017 and 2018.
Chapter 3, the Pulmonary Drug Delivery Systems competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Drug Delivery Systems breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Pulmonary Drug Delivery Systems market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Pulmonary Drug Delivery Systems sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Pulmonary Drug Delivery Systems Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Nebulizers
      • 1.2.2 Dry Powder Inhaler (DPI)
      • 1.2.3 Metered Dose Inhaler (MDI)
    • 1.3 Market Analysis by Applications
      • 1.3.1 COPD
      • 1.3.2 Asthma
      • 1.3.3 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 3M
      • 2.1.1 Business Overview
      • 2.1.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 3M Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 GSK
      • 2.2.1 Business Overview
      • 2.2.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 GSK Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 AstraZeneca
      • 2.3.1 Business Overview
      • 2.3.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 AstraZeneca Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Cipla
      • 2.4.1 Business Overview
      • 2.4.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Cipla Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Chiesi
      • 2.5.1 Business Overview
      • 2.5.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Chiesi Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Boehringer Ingelheim
      • 2.6.1 Business Overview
      • 2.6.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Aptar
      • 2.7.1 Business Overview
      • 2.7.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Aptar Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Novartis
      • 2.8.1 Business Overview
      • 2.8.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Novartis Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Philips Respironics
      • 2.9.1 Business Overview
      • 2.9.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Philips Respironics Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Omron Healthcare
      • 2.10.1 Business Overview
      • 2.10.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 PARI
      • 2.11.1 Business Overview
      • 2.11.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 PARI Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Skyepharma
      • 2.12.1 Business Overview
      • 2.12.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Skyepharma Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 CareFusion
      • 2.13.1 Business Overview
      • 2.13.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 CareFusion Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Shanghai Huarui
      • 2.14.1 Business Overview
      • 2.14.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Taian Character
      • 2.15.1 Business Overview
      • 2.15.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Taian Character Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Chia Tai Tianqing
      • 2.16.1 Business Overview
      • 2.16.2 Pulmonary Drug Delivery Systems Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Pulmonary Drug Delivery Systems Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Pulmonary Drug Delivery Systems Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Pulmonary Drug Delivery Systems Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Pulmonary Drug Delivery Systems Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Pulmonary Drug Delivery Systems Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Pulmonary Drug Delivery Systems Market Analysis by Regions

    • 4.1 Global Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Pulmonary Drug Delivery Systems Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Pulmonary Drug Delivery Systems Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 4.3 Europe Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 4.5 South America Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)

    5 North America Pulmonary Drug Delivery Systems by Country

    • 5.1 North America Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Country
      • 5.1.1 North America Pulmonary Drug Delivery Systems Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Pulmonary Drug Delivery Systems Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 5.3 Canada Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)

    6 Europe Pulmonary Drug Delivery Systems by Country

    • 6.1 Europe Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Pulmonary Drug Delivery Systems Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Pulmonary Drug Delivery Systems Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 6.3 UK Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 6.4 France Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 6.5 Russia Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 6.6 Italy Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Pulmonary Drug Delivery Systems by Country

    • 7.1 Asia-Pacific Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Pulmonary Drug Delivery Systems Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Pulmonary Drug Delivery Systems Revenue and Market Share by Country (2014-2019)
    • 7.2 China Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 7.3 Japan Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 7.4 Korea Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 7.5 India Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)

    8 South America Pulmonary Drug Delivery Systems by Country

    • 8.1 South America Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Country
      • 8.1.1 South America Pulmonary Drug Delivery Systems Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Pulmonary Drug Delivery Systems Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Pulmonary Drug Delivery Systems by Countries

    • 9.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Pulmonary Drug Delivery Systems Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Pulmonary Drug Delivery Systems Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Pulmonary Drug Delivery Systems Sales and Growth Rate (2014-2019)

    10 Global Pulmonary Drug Delivery Systems Market Segment by Type

    • 10.1 Global Pulmonary Drug Delivery Systems Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Pulmonary Drug Delivery Systems Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Pulmonary Drug Delivery Systems Revenue and Market Share by Type (2014-2019)
    • 10.2 Nebulizers Sales Growth and Price
      • 10.2.1 Global Nebulizers Sales Growth (2014-2019)
      • 10.2.2 Global Nebulizers Price (2014-2019)
    • 10.3 Dry Powder Inhaler (DPI) Sales Growth and Price
      • 10.3.1 Global Dry Powder Inhaler (DPI) Sales Growth (2014-2019)
      • 10.3.2 Global Dry Powder Inhaler (DPI) Price (2014-2019)
    • 10.4 Metered Dose Inhaler (MDI) Sales Growth and Price
      • 10.4.1 Global Metered Dose Inhaler (MDI) Sales Growth (2014-2019)
      • 10.4.2 Global Metered Dose Inhaler (MDI) Price (2014-2019)

    11 Global Pulmonary Drug Delivery Systems Market Segment by Application

    • 11.1 Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2014-2019)
    • 11.2 COPD Sales Growth (2014-2019)
    • 11.3 Asthma Sales Growth (2014-2019)
    • 11.4 Others Sales Growth (2014-2019)

    12 Pulmonary Drug Delivery Systems Market Forecast (2019-2024)

    • 12.1 Global Pulmonary Drug Delivery Systems Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Pulmonary Drug Delivery Systems Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Pulmonary Drug Delivery Systems Market Forecast (2019-2024)
      • 12.2.2 Europe Pulmonary Drug Delivery Systems Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Pulmonary Drug Delivery Systems Market Forecast (2019-2024)
      • 12.2.4 South America Pulmonary Drug Delivery Systems Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Pulmonary Drug Delivery Systems Market Forecast (2019-2024)
    • 12.3 Pulmonary Drug Delivery Systems Market Forecast by Type (2019-2024)
      • 12.3.1 Global Pulmonary Drug Delivery Systems Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Pulmonary Drug Delivery Systems Market Share Forecast by Type (2019-2024)
    • 12.4 Pulmonary Drug Delivery Systems Market Forecast by Application (2019-2024)
      • 12.4.1 Global Pulmonary Drug Delivery Systems Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Pulmonary Drug Delivery Systems Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Pulmonary Drug Delivery Systems . Industry analysis & Market Report on Pulmonary Drug Delivery Systems is a syndicated market report, published as Global Pulmonary Drug Delivery Systems Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Pulmonary Drug Delivery Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,784.00
      		4,176.00
      		5,568.00
      		3,250.32
      		4,875.48
      		6,500.64
      		549,631.20
      		824,446.80
      		1,099,262.40
      		290,336.40
      		435,504.60
      		580,672.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo